Tag: Prescription Drugs
Lilly to Seek FDA Approval for New Drug for Alzheimer Disease
Donanemab has already received a 'breakthrough therapy' designation from the FDA
Sotagliflozin Ups Days Alive, Out of Hospital in T2DM, Heart Failure
Increase in rate of days alive and out of hospital mainly due to drop in rate of days dead for patients with T2DM, worsening heart failure
Monoclonal Antibodies for COVID-19 Effective for Transplant Patients
Favorable outcomes, minimal adverse effects seen in solid organ transplant recipients who received monoclonal antibody therapy for COVID-19
Ibrutinib + Venetoclax Promising for Chronic Lymphocytic Leukemia
Seventy-five percent of patients achieved a best response of bone marrow-undetectable measurable residual disease remission
Claims Data Indicate Overuse of Levothyroxine in the U.S.
Among patients with available thyroid function test results, levothyroxine often initiated to treat subclinical hypothyroidism (61 percent)
Certain Antihypertensive Agents May Aid Cognition in Elderly
Memory recall better for up to three years with blood-brain barrier-crossing renin-angiotensin drugs versus nonpenetrant counterparts
Eptinezumab Speeds Pain, Symptom Relief From Migraine Attack
Headache pain, most bothersome symptom resolved more quickly with IV infusion of eptinezumab versus placebo during migraine attack
U.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVID-19
Oral medications patients take when symptoms first appear are being tested, but initial results are not expected for several months
Cognitive Outcomes Studied for In Utero Exposure to Antiseizure Meds
No significant differences in language development seen at age 2 years for children born to mothers with epilepsy
Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D
Lower exacerbation counts, fewer health care encounters for asthma symptoms seen in asthma patients with T2D initiating GLP-1R agonists
